These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 18449386)
1. Dr. David Rimm is interviewed by Feras Akbik. Rimm D Yale J Biol Med; 2007 Dec; 80(4):183-5. PubMed ID: 18449386 [TBL] [Abstract][Full Text] [Related]
2. Multi-Omics of Single Cells: Strategies and Applications. Bock C; Farlik M; Sheffield NC Trends Biotechnol; 2016 Aug; 34(8):605-608. PubMed ID: 27212022 [TBL] [Abstract][Full Text] [Related]
3. The potential of serum proteomics for detection of cancer: promise or only hope? Krueger KE Onkologie; 2006 Nov; 29(11):498-9. PubMed ID: 17068383 [No Abstract] [Full Text] [Related]
4. Corporate innovation as an engine for change: panel discussion. Friedman BA; Cartwright G; Okrongly D; Soenksen D; Newburger M Arch Pathol Lab Med; 2009 Apr; 133(4):561-7. PubMed ID: 19391653 [No Abstract] [Full Text] [Related]
6. Digital pathology and image analysis in tissue biomarker research. Hamilton PW; Bankhead P; Wang Y; Hutchinson R; Kieran D; McArt DG; James J; Salto-Tellez M Methods; 2014 Nov; 70(1):59-73. PubMed ID: 25034370 [TBL] [Abstract][Full Text] [Related]
7. Hierarchical normalized cuts: unsupervised segmentation of vascular biomarkers from ovarian cancer tissue microarrays. Janowczyk A; Chandran S; Singh R; Sasaroli D; Coukos G; Feldman MD; Madabhushi A Med Image Comput Comput Assist Interv; 2009; 12(Pt 1):230-8. PubMed ID: 20425992 [TBL] [Abstract][Full Text] [Related]
8. Digital pathology at the crossroads of major health care trends: corporate innovation as an engine for change. Soenksen D Arch Pathol Lab Med; 2009 Apr; 133(4):555-9. PubMed ID: 19391651 [No Abstract] [Full Text] [Related]
9. Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer. Brennan DJ; Kelly C; Rexhepaj E; Dervan PA; Duffy MJ; Gallagher WM Cancer Genomics Proteomics; 2007; 4(3):121-34. PubMed ID: 17878516 [TBL] [Abstract][Full Text] [Related]
10. Driving to pathology's future: corporate innovation as an engine for change. Newburger M Arch Pathol Lab Med; 2009 Apr; 133(4):560. PubMed ID: 19391652 [No Abstract] [Full Text] [Related]
11. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica. Dobrić I Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489 [TBL] [Abstract][Full Text] [Related]
12. A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis. Statnikov A; Aliferis CF; Tsamardinos I; Hardin D; Levy S Bioinformatics; 2005 Mar; 21(5):631-43. PubMed ID: 15374862 [TBL] [Abstract][Full Text] [Related]
13. Automated detection of regions of interest for tissue microarray experiments: an image texture analysis. Karaçali B; Tözeren A BMC Med Imaging; 2007 Mar; 7():2. PubMed ID: 17349041 [TBL] [Abstract][Full Text] [Related]
14. Interview: A perspective on personalized medicine: Dr David Korn. Korn D Per Med; 2012 May; 9(3):259-263. PubMed ID: 29758794 [TBL] [Abstract][Full Text] [Related]
15. Next generation of network medicine: interdisciplinary signaling approaches. Korcsmaros T; Schneider MV; Superti-Furga G Integr Biol (Camb); 2017 Feb; 9(2):97-108. PubMed ID: 28106223 [TBL] [Abstract][Full Text] [Related]
16. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong! Høilund-Carlsen PF Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853 [TBL] [Abstract][Full Text] [Related]
17. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Huang DW; Sherman BT; Tan Q; Collins JR; Alvord WG; Roayaei J; Stephens R; Baseler MW; Lane HC; Lempicki RA Genome Biol; 2007; 8(9):R183. PubMed ID: 17784955 [TBL] [Abstract][Full Text] [Related]